Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection

Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity of occurrence, there is no standardized consensus for treatment. Early recognition of symptoms and a multidisciplinary approach with input from transplant hepatology and hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiparizoska, Sara, Nguyen, Veronica, Rangnekar, Amol S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875985/
https://www.ncbi.nlm.nih.gov/pubmed/36713282
http://dx.doi.org/10.14309/crj.0000000000000971
_version_ 1784878068349796352
author Kiparizoska, Sara
Nguyen, Veronica
Rangnekar, Amol S.
author_facet Kiparizoska, Sara
Nguyen, Veronica
Rangnekar, Amol S.
author_sort Kiparizoska, Sara
collection PubMed
description Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity of occurrence, there is no standardized consensus for treatment. Early recognition of symptoms and a multidisciplinary approach with input from transplant hepatology and hematology is important to determine a treatment plan and improve outcomes. We present a unique case of a 49-year-old woman who developed GVHD during a coronavirus disease 2019 (COVID-19) infection 3 months after receiving a liver transplant. More data are needed to determine whether COVID-19 infection itself correlates with a risk of developing GVHD.
format Online
Article
Text
id pubmed-9875985
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-98759852023-01-26 Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection Kiparizoska, Sara Nguyen, Veronica Rangnekar, Amol S. ACG Case Rep J Case Report Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity of occurrence, there is no standardized consensus for treatment. Early recognition of symptoms and a multidisciplinary approach with input from transplant hepatology and hematology is important to determine a treatment plan and improve outcomes. We present a unique case of a 49-year-old woman who developed GVHD during a coronavirus disease 2019 (COVID-19) infection 3 months after receiving a liver transplant. More data are needed to determine whether COVID-19 infection itself correlates with a risk of developing GVHD. Wolters Kluwer 2023-01-25 /pmc/articles/PMC9875985/ /pubmed/36713282 http://dx.doi.org/10.14309/crj.0000000000000971 Text en © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Kiparizoska, Sara
Nguyen, Veronica
Rangnekar, Amol S.
Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection
title Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection
title_full Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection
title_fullStr Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection
title_full_unstemmed Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection
title_short Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection
title_sort graft-vs-host disease in a liver transplant patient with covid-19 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875985/
https://www.ncbi.nlm.nih.gov/pubmed/36713282
http://dx.doi.org/10.14309/crj.0000000000000971
work_keys_str_mv AT kiparizoskasara graftvshostdiseaseinalivertransplantpatientwithcovid19infection
AT nguyenveronica graftvshostdiseaseinalivertransplantpatientwithcovid19infection
AT rangnekaramols graftvshostdiseaseinalivertransplantpatientwithcovid19infection

Ejemplares similares